Skip to main content

Table 1 Selection Criteria

From: Expanding the role of PSMA PET in active surveillance

Study Recommendation

Clinical stage

Histological characteristics

PSA

Royal Marsden Hospital

T1-T2

• Gleason ≤3 + 4.

• ≤50% core involvement

• ≤5% Gleason pattern 4

• Absence of cribriform architecture or intraductal carcinoma on prostate biopsy

PSA ≤15